| 1 |
201137_s_at |
major histocompatibility complex, class II, DP beta
1 |
HLA-DPB1 |
6p21.3 |
NM_002121.1 |
Hs.814 |
100.0 |
Below |
24.2 |
| 2 |
202113_s_at |
sorting nexin 2 |
SNX2 |
5q23 |
AF043453.1 |
Hs.11183 |
100.0 |
Below |
4.2 |
| 3 |
202114_at |
sorting nexin 2 |
SNX2 |
5q23 |
NM_003100.1 |
Hs.11183 |
100.0 |
Below |
4.7 |
| 4 |
203675_at |
nucleobindin 2 |
NUCB2 |
11p15.1-p14 |
NM_005013.1 |
Hs.3164 |
100.0 |
Above |
3.7 |
| 5 |
204670_x_at |
major histocompatibility complex, class II, DR beta
3 |
HLA-DRB3 |
6p21.3 |
NM_002125.1 |
Hs.308026 |
100.0 |
Below |
15.3 |
| 6 |
205297_s_at |
CD79B antigen (immunoglobulin-associated beta) |
CD79B |
17q23 |
NM_000626.1 |
Hs.89575 |
100.0 |
Below |
21.8 |
| 7 |
205456_at |
CD3E antigen, epsilon polypeptide (TiT3 complex) |
CD3E |
11q23 |
NM_000733.1 |
Hs.3003 |
100.0 |
Above |
20.8 |
| 8 |
206398_s_at |
CD19 antigen |
CD19 |
16p11.2 |
NM_001770.1 |
Hs.96023 |
100.0 |
Below |
5693.6 |
| 9 |
208306_x_at |
major histocompatibility complex, class II, DR beta
4 |
HLA-DRB4 |
6p21.3 |
NM_021983.2 |
Hs.318720 |
100.0 |
Below |
9.8 |
| 10 |
208894_at |
major histocompatibility complex, class II, DR alpha |
HLA-DRA |
6p21.3 |
M60334.1 |
Hs.76807 |
100.0 |
Below |
27.5 |
| 11 |
209312_x_at |
major histocompatibility complex, class II, DR beta
1 |
HLA-DRB1 |
6p21.3 |
U65585.1 |
Hs.375570 |
100.0 |
Below |
14.6 |
| 12 |
209619_at |
CD74 antigen (invariant polypeptide of major histocompatibility
complex, class II antigen-associated) |
CD74 |
5q32 |
K01144.1 |
Hs.84298 |
100.0 |
Below |
18.9 |
| 13 |
210116_at |
SH2 domain protein 1A, Duncan's disease (lymphoproliferative
syndrome) |
SH2D1A |
Xq25-q26 |
AF072930.1 |
Hs.151544 |
100.0 |
Above |
159.0 |
| 14 |
210982_s_at |
major histocompatibility complex, class II, DR alpha |
HLA-DRA |
6p21.3 |
M60333.1 |
Hs.76807 |
100.0 |
Below |
32.5 |
| 15 |
211990_at |
major histocompatibility complex, class II, DP alpha
1 |
HLA-DPA1 |
6p21.3 |
M27487.1 |
Hs.914 |
100.0 |
Below |
29.4 |
| 16 |
211991_s_at |
major histocompatibility complex, class II, DP alpha
1 |
HLA-DPA1 |
6p21.3 |
M27487.1 |
Hs.914 |
100.0 |
Below |
35.9 |
| 17 |
213539_at |
CD3D antigen, delta polypeptide (TiT3 complex) |
CD3D |
11q23 |
NM_000732.1 |
Hs.95327 |
100.0 |
Above |
37.0 |
| 18 |
214049_x_at |
CD7 antigen (p41) |
CD7 |
17q25.2-q25.3 |
AI829961 |
Hs.36972 |
100.0 |
Above |
327.3 |
| 19 |
214551_s_at |
CD7 antigen (p41) |
CD7 |
17q25.2-q25.3 |
NM_006137.2 |
Hs.36972 |
100.0 |
Above |
241.8 |
| 20 |
217147_s_at |
T-cell receptor interacting molecule |
TRIM |
3q13 |
AJ240085.1 |
Hs.138701 |
100.0 |
Above |
43.6 |
| 21 |
217478_s_at |
MHC,
class IIa, HLA-DMA |
HLA-DMA |
|
X76775 |
|
100.0 |
Below |
14.1 |
| 22 |
221969_at |
paired box gene 5 (B-cell lineage specific activator
protein) |
PAX5 |
9p13 |
BF510692 |
Hs.22030 |
100.0 |
Below |
3922.0 |
| 23 |
227646_at |
early B-cell factor |
EBF |
5q34 |
BG435302 |
Hs.32425 |
100.0 |
Below |
79.2 |
| 24 |
229487_at |
Homo sapiens cDNA FLJ39389 |
|
|
W73890 |
Hs.120785 |
100.0 |
Below |
7685.7 |
| 25 |
229838_at |
Homo sapiens cDNA FLJ39156 |
|
|
AI377271 |
Hs.376140 |
100.0 |
Above |
13.4 |
| 26 |
232204_at |
early B-cell factor |
EBF |
5q34 |
AF208502.1 |
Hs.32425 |
100.0 |
Below |
7112.4 |
| 27 |
266_s_at |
CD24 antigen (small cell lung carcinoma cluster
4 antigen) |
CD24 |
6q21 |
L33930 |
Hs.286124 |
91.3 |
Below |
135.5 |
| 28 |
39318_at |
T-cell leukemia/lymphoma 1A |
TCL1A |
14q32.1 |
X82240 |
Hs.2484 |
91.3 |
Below |
18114.7 |
| 29 |
203965_at |
ubiquitin specific protease 20 |
USP20 |
9q34.12-q34.13 |
NM_006676.1 |
Hs.5452 |
91.3 |
Above |
9.6 |
| 30 |
204891_s_at |
lymphocyte-specific protein tyrosine kinase |
LCK |
1p34.3 |
NM_005356.1 |
Hs.1765 |
91.3 |
Above |
14.3 |
| 31 |
205255_x_at |
transcription factor 7 (T-cell specific, HMG-box) |
TCF7 |
5q31.1 |
NM_003202.1 |
Hs.169294 |
91.3 |
Above |
8.5 |
| 32 |
207655_s_at |
B-cell linker |
BLNK |
10q23.2-q23.33 |
NM_013314.1 |
Hs.167746 |
91.3 |
Below |
133.1 |
| 33 |
209771_x_at |
CD24 antigen (small cell lung carcinoma cluster
4 antigen) |
CD24 |
6q21 |
AA761181 |
Hs.286124 |
91.3 |
Below |
51.5 |
| 34 |
211796_s_at |
T cell receptor beta locus |
TRB |
7q34 |
AF043179.1 |
Hs.303157 |
91.3 |
Above |
21.5 |
| 35 |
213792_s_at |
insulin receptor |
INSR |
19p13.3-p13.2 |
AA485908 |
Hs.89695 |
91.3 |
Below |
8.6 |
| 36 |
215193_x_at |
major histocompatibility complex, class II, DR beta
3 |
HLA-DRB3 |
6p21.3 |
AJ297586.1 |
Hs.308026 |
91.3 |
Below |
16.7 |
| 37 |
216379_x_at |
KIAA1919 protein |
KIAA1919 |
6q22.1 |
AK000168.1 |
Hs.381004 |
91.3 |
Below |
56.0 |
| 38 |
219191_s_at |
bridging integrator 2 |
BIN2 |
12q13 |
NM_016293.1 |
Hs.14770 |
91.3 |
Above |
264.1 |
| 39 |
219563_at |
hypothetical protein FLJ21276 |
FLJ21276 |
14q32.2 |
NM_024633.1 |
Hs.41502 |
91.3 |
Below |
5.8 |
| 40 |
219724_s_at |
KIAA0748 gene product |
KIAA0748 |
12q12 |
NM_014796.1 |
Hs.33187 |
91.3 |
Above |
11.4 |
| 41 |
221750_at |
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1
(soluble) |
HMGCS1 |
5p14-p13 |
BG035985 |
Hs.77910 |
91.3 |
Above |
3.5 |
| 42 |
226157_at |
Homo sapiens cDNA FLJ39131 |
|
|
AI569747 |
Hs.379018 |
91.3 |
Above |
4.6 |
| 43 |
226496_at |
hypothetical protein FLJ22611 |
FLJ22611 |
9p11.1 |
BG291039 |
Hs.27774 |
91.3 |
Below |
7.7 |
| 44 |
204214_s_at |
RAB32, member RAS oncogene family |
RAB32 |
6q24.3 |
NM_006834.1 |
Hs.32217 |
90.6 |
Above |
137.0 |
| 45 |
204777_s_at |
mal, T-cell differentiation protein |
MAL |
2cen-q13 |
NM_002371.2 |
Hs.80395 |
90.6 |
Above |
95.2 |
| 46 |
204890_s_at |
lymphocyte-specific protein tyrosine kinase |
LCK |
1p34.3 |
U07236.1 |
Hs.1765 |
90.6 |
Above |
19.4 |
| 47 |
205049_s_at |
CD79A antigen (immunoglobulin-associated alpha) |
CD79A |
19q13.2 |
NM_001783.1 |
Hs.79630 |
90.6 |
Below |
11.6 |
| 48 |
205254_x_at |
transcription factor 7 (T-cell specific, HMG-box) |
TCF7 |
5q31.1 |
AW027359 |
Hs.169294 |
90.6 |
Above |
377.1 |
| 49 |
205504_at |
Bruton agammaglobulinemia tyrosine kinase |
BTK |
Xq21.33-q22 |
NM_000061.1 |
Hs.159494 |
90.6 |
Below |
7.3 |
| 50 |
210915_x_at |
T cell receptor beta locus |
TRB |
7q34 |
M15564.1 |
Hs.303157 |
90.6 |
Above |
16.2 |
| 51 |
211211_x_at |
SH2 domain protein 1A, Duncan's disease (lymphoproliferative
syndrome) |
SH2D1A |
Xq25-q26 |
AF100542.1 |
Hs.151544 |
90.6 |
Above |
2103.7 |
| 52 |
213830_at |
T cell receptor delta locus |
TRD |
14q11.2 |
AW007751 |
Hs.2014 |
90.6 |
Above |
7379.7 |
| 53 |
216191_s_at |
T cell receptor delta locus |
TRD |
14q11.2 |
X72501.1 |
Hs.2014 |
90.6 |
Above |
253.1 |
| 54 |
217143_s_at |
T cell receptor delta locus |
TRD |
14q11.2 |
X06557.1 |
Hs.2014 |
90.6 |
Above |
150.1 |
| 55 |
219528_s_at |
B-cell CLL/lymphoma 11B (zinc finger protein) |
BCL11B |
14q32.31-q32.32 |
NM_022898.1 |
Hs.57987 |
90.6 |
Above |
11.9 |
| 56 |
220418_at |
ubiquitin associated and SH3 domain containing,
A |
UBASH3A |
21q22.3 |
NM_018961.1 |
Hs.183924 |
90.6 |
Above |
766.4 |
| 57 |
222895_s_at |
B-cell CLL/lymphoma 11B (zinc finger protein) |
BCL11B |
14q32.31-q32.32 |
AA918317 |
Hs.57987 |
90.6 |
Above |
12.1 |
| 58 |
223553_s_at |
hypothetical protein FLJ22570 |
FLJ22570 |
5q35.3 |
BC004564.1 |
Hs.122559 |
90.6 |
Below |
7.0 |
| 59 |
225090_at |
HRD1 protein |
HRD1 |
11q12 |
AA844682 |
Hs.334819 |
90.6 |
Below |
3.8 |
| 60 |
226459_at |
Homo sapiens gastric cancer-related protein GCYS-20
(gcys-20) mRNA, complete cds |
|
|
AW575754 |
Hs.86437 |
90.6 |
Below |
11.9 |
| 61 |
228314_at |
Homo sapiens cDNA FLJ37485 |
|
|
BE877357 |
Hs.24181 |
90.6 |
Below |
5.1 |
| 62 |
201384_s_at |
membrane component, chromosome 17, surface marker
2 (ovarian carcinoma antigen CA125) |
M17S2 |
17q21.1 |
NM_005899.1 |
Hs.277721 |
83.8 |
Above |
3.3 |
| 63 |
202540_s_at |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
HMGCR |
5q13.3-q14 |
NM_000859.1 |
Hs.11899 |
83.8 |
Above |
4.6 |
| 64 |
203198_at |
cyclin-dependent kinase 9 (CDC2-related kinase) |
CDK9 |
9q34.1 |
NM_001261.1 |
Hs.150423 |
83.8 |
Below |
5.2 |
| 65 |
203932_at |
major histocompatibility complex, class II, DM beta |
HLA-DMB |
6p21.3 |
NM_002118.1 |
Hs.1162 |
83.8 |
Below |
8.2 |
| 66 |
204613_at |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
PLCG2 |
16q24.1 |
NM_002661.1 |
Hs.75648 |
83.8 |
Below |
4.0 |
| 67 |
205267_at |
POU domain, class 2, associating factor 1 |
POU2AF1 |
11q23.1 |
NM_006235.1 |
Hs.2407 |
83.8 |
Below |
11.7 |
| 68 |
208650_s_at |
CD24 antigen (small cell lung carcinoma cluster
4 antigen) |
CD24 |
6q21 |
BG327863 |
Hs.286124 |
83.8 |
Below |
110.8 |
| 69 |
208651_x_at |
CD24 antigen (small cell lung carcinoma cluster
4 antigen) |
CD24 |
6q21 |
M58664.1 |
Hs.286124 |
83.8 |
Below |
49.3 |
| 70 |
209995_s_at |
T-cell leukemia/lymphoma 1A |
TCL1A |
14q32.1 |
BC003574.1 |
Hs.2484 |
83.8 |
Below |
20166.2 |
| 71 |
210038_at |
protein kinase C, theta |
PRKCQ |
10p15 |
AL137145 |
Hs.211593 |
83.8 |
Above |
12.7 |
| 72 |
211126_s_at |
cysteine and glycine-rich protein 2 |
CSRP2 |
12q21.1 |
U46006.1 |
Hs.10526 |
83.8 |
Below |
16.8 |
| 73 |
220068_at |
pre-B lymphocyte gene 3 |
VPREB3 |
22q11.23 |
NM_013378.1 |
Hs.136713 |
83.8 |
Below |
6559.8 |
| 74 |
226245_at |
Homo sapiens mRNA; cDNA DKFZp451C132 |
|
|
U55984 |
Hs.356531 |
83.8 |
Above |
9.1 |
| 75 |
202615_at |
Homo sapiens mRNA; cDNA DKFZp686D0521 |
|
|
BF222895 |
Hs.356786 |
82.2 |
Above |
3.1 |
| 76 |
224861_at |
Homo sapiens cDNA FLJ31057 |
|
|
BF477658 |
Hs.296261 |
82.2 |
Above |
3.5 |
| 77 |
201194_at |
selenoprotein W, 1 |
SEPW1 |
19q13.3 |
NM_003009.1 |
Hs.14231 |
82.0 |
Above |
4.0 |
| 78 |
201349_at |
solute carrier family 9 (sodium/hydrogen exchanger),
isoform 3 regulatory factor 1 |
SLC9A3R1 |
17q25.2 |
NM_004252.1 |
Hs.184276 |
82.0 |
Above |
2.7 |
| 79 |
202539_s_at |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
HMGCR |
5q13.3-q14 |
AL518627 |
Hs.11899 |
82.0 |
Above |
3.5 |
| 80 |
203588_s_at |
transcription factor Dp-2 (E2F dimerization partner
2) |
TFDP2 |
3q23 |
BG034328 |
Hs.19131 |
82.0 |
Above |
18.5 |
| 81 |
204852_s_at |
protein tyrosine phosphatase, non-receptor type
7 |
PTPN7 |
1q32.1 |
NM_002832.1 |
Hs.35 |
82.0 |
Above |
9.3 |
| 82 |
207434_s_at |
FXYD domain containing ion transport regulator 2 |
FXYD2 |
11q23 |
NM_021603.1 |
Hs.19520 |
82.0 |
Above |
15.7 |
| 83 |
208872_s_at |
DNA segment, single copy probe LNS-CAI/LNS-CAII
(deleted in polyposis) |
D5S346 |
5q22-q23 |
AA814140 |
Hs.178112 |
82.0 |
Below |
2.7 |
| 84 |
209200_at |
MADS box transcription enhancer factor 2, polypeptide
C (myocyte enhancer factor 2C) |
MEF2C |
5q14 |
N22468 |
Hs.78995 |
82.0 |
Below |
9.1 |
| 85 |
212795_at |
KIAA1033 protein |
KIAA1033 |
12q24.11 |
AL137753.1 |
Hs.12144 |
82.0 |
Below |
2.5 |
| 86 |
212827_at |
immunoglobulin heavy constant mu |
IGHM |
14q32.33 |
X17115.1 |
Hs.153261 |
82.0 |
Below |
16.1 |
| 87 |
213193_x_at |
T cell receptor beta locus |
TRB |
7q34 |
AL559122 |
Hs.303157 |
82.0 |
Above |
11.1 |
| 88 |
221002_s_at |
tetraspanin similar to TM4SF9 |
DC-TM4F2 |
10q23.2 |
NM_030927.1 |
Hs.101395 |
82.0 |
Below |
2.1 |
| 89 |
225314_at |
hypothetical protein MGC45416 |
MGC45416 |
4p12 |
BG291649 |
Hs.95835 |
82.0 |
Above |
5.7 |
| 90 |
227432_s_at |
insulin receptor |
INSR |
19p13.3-p13.2 |
AI215106 |
Hs.89695 |
82.0 |
Below |
6.9 |
| 91 |
203332_s_at |
inositol polyphosphate-5-phosphatase, 145kDa |
INPP5D |
2q36-q37 |
NM_005541.1 |
Hs.155939 |
81.5 |
Below |
2.4 |
| 92 |
203589_s_at |
transcription factor Dp-2 (E2F dimerization partner
2) |
TFDP2 |
3q23 |
NM_006286.1 |
Hs.19131 |
81.5 |
Above |
37.6 |
| 93 |
205674_x_at |
FXYD domain containing ion transport regulator 2 |
FXYD2 |
11q23 |
NM_001680.2 |
Hs.19520 |
81.5 |
Above |
13.0 |
| 94 |
209881_s_at |
linker for activation of T cells |
LAT |
16q13 |
AF036905.1 |
Hs.83496 |
81.5 |
Above |
1953.6 |
| 95 |
211005_at |
linker for activation of T cells |
LAT |
16q13 |
AF036906.1 |
Hs.83496 |
81.5 |
Above |
70.4 |
| 96 |
211075_s_at |
CD47 |
|
|
Z25521.1 |
|
81.5 |
Above |
2.1 |
| 97 |
211210_x_at |
SH2 domain protein 1A, Duncan's disease (lymphoproliferative
syndrome) |
SH2D1A |
Xq25-q26 |
AF100539.1 |
Hs.151544 |
81.5 |
Above |
315.1 |
| 98 |
213601_at |
slit homolog 1 (Drosophila) |
SLIT1 |
10q23.3-q24 |
AB011537.2 |
Hs.133466 |
81.5 |
Above |
1877.2 |
| 99 |
213857_s_at |
CD47 antigen (Rh-related antigen, integrin-associated
signal transducer) |
CD47 |
3q13.1-q13.2 |
BG230614 |
Hs.82685 |
81.5 |
Above |
2.2 |
| 100 |
214924_s_at |
KIAA1042 protein |
KIAA1042 |
3p25.3-p24.1 |
AK000754.1 |
Hs.6705 |
81.5 |
Below |
2.4 |